Company Information

CSM, a Clinigen company, combines its unique focus on clinical trial supplies and biological sample management with Clinigen’s market leading comparator drug sourcing offering. Being part of Clinigen’s global facility and depot network, CSM is committed to ensuring clinical trials are a success, regardless of size or scope.

Company Information

Clinical Services International (CSI) is a global leader of sourcing and management of commercially available medicines (comparators, concomitant medication) for clinical trials.
Headquartered in London and with operations in UK, Germany, Denmark, Japan and USA, we provide efficient solutions and serve worldwide trials. Our longstanding experience and relationships with manufacturers, enables us to provide custom made solutions to address the most complex requirements.
We accelerate drug development and reduce timelines by providing a fully integrated service.
Address Regulatory, Quality, Operational, Clinical requirements
Manage the entire supply chain and offer tailor-made solutions
Comprehensive expertise in Oncology and Biosimilar products.
Advanced Technology and Innovative approach
Trusted partner of leading Biopharmaceuticals, CROs and CMOs.
www.csint.com

Company Information

CSMC Technologies Corporation (“CSMC”) is a subsidiary of China
Resources Microelectronics Limited, which is the technology arm
of China Resources (Holdings) Company Limited. Pioneering the
open foundry business model in China since 1997, CSMC and its
subsidiaries provide IC manufacturing services for customers.

6-inch production lines – CSMC Technologies Fab 1 Co. Ltd. is the first
open 6-inch foundry in China, which contains a clean room of 9,400
square meters and focuses on HV analog technologies, new power
electronics & MEMS. 6-inch capacity has attained 110,000 wafers per
month to make CSMC the largest foundry in China.

The establishment of the joint venture with China Resources
Group, 8-inch production lines – CSMC Technologies Fab 2 Co., Ltd.,
its’ cleanroom area will reach 18,000 square meters, the capacity
expanded to 60,000 8-inch wafers per month and is expected to
continue expanding. The process technologies will be enhanced to
0.13μm.

Company Information

Estabilished in 1998, Dryce is a Joint Venture between Gruppo Marotta and Rivoira, a Praxair Group company. Praxair is a leading Company in the production and distribution of gases and in the development of new technologies.

Our Mission
Give our Customers the Know-How and the Solutions for improving their business.
The passion for our job, our desire to grow, the commitment to improve the environmental quality and the sharing of resources with the poor of the world are the power that leads us every day to the improvement